SAUDICHEM
7.44 SAR
-1.19%
Today
-1.32%
1D
Last seen at Wed, 25 Feb 2026 12:33:00 GMT+3
Market is open
Sun
9:00 AM ~ 2:00 PM
Mon
9:00 AM ~ 2:00 PM
Tue
9:00 AM ~ 2:00 PM
Wed
9:00 AM ~ 2:00 PM
Thu
9:00 AM ~ 2:00 PM
Fri
Closed
Sat
Closed
Performance
1 Day
- 1.32 %
1 Week
- 6.09 %
1 Month
+ 3.14 %
3 Month
+ 4.71 %
6 Month
+ 10.53 %
1 Year
- 20.50 %
Information
Name
Saudi Chemical
Currency
SAR
Standard Leverage
1X
Market Cap
6.00B
Avg Daily Volume
3.95M
52 Week High
10.72 SAR
52 Week Low
6.06 SAR
Trading Hours
See hours
Business Summary
Saudi Chemical Holding Company manufactures, distributes, and retails medicines, medical materials and solutions, pharmaceutical preparations, medical and surgical tools, equipment, instruments, hospital and medical centre supplies and spare parts, detergents, and food products. The company operates through three segments: Explosives; Medicine and Medical Supplies; and Production of Ammonium Nitrate. It also manufactures and sells explosives and related products for civilian and military use; provides technical support services for blasting; and the manufacture of ammonium nitrate. In addition, the company engages in the wholesale and retail trade of cosmetics, perfumes, beauty soups, and other supplies; and packaging and storing of medicines and other medical products. It operates in the Kingdom of Saudi Arabia and internationally. The company was founded in 1972 and is based in Riyadh, the Kingdom of Saudi Arabia.
Frequently Asked Questions
What are healthcare stocks and why are they important to investors?
Healthcare stocks include pharmaceutical companies, biotech firms, hospitals, and medical device manufacturers.
Are healthcare stocks less volatile?
Generally yes. Because healthcare is a necessity, demand remains relatively steady, making the sector less sensitive to economic cycles.
What drives growth in healthcare investments?
Aging populations, technological advancements, and increased healthcare spending contribute to long-term growth in the sector.
What are the risks of investing in healthcare?
Regulatory changes, drug approval delays, and legal challenges can affect the profitability and stock prices of healthcare companies.
